Allstate (0HCZ) Share Forecast & Price Target
0HCZ Analyst Ratings
Moderate Buy
9Buy8Hold3Sell
Based on 20 analysts giving stock ratings to Allstate in the past 3 months
0HCZ Stock 12 Month Forecast
Average Price Target
$264.44▲(0.33% Upside)Based on 20 Wall Street analysts offering 12 month price targets for Allstate in the last 3 months. The average price target is $264.44 with a high forecast of $315.00 and a low forecast of $215.00. The average price target represents a 0.33% change from the last price of $263.57.
Past 12 Months12 Month ForecastDec2025Sep2026
High$315.00
Average$264.44
Low$215.00
Highest Price TargetHighest$315.00Average Price Target$264.44Lowest Price TargetLowest$215.00
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Joshua Shanker | Bank of America Securities | ― | buy | ― | Reiterated | 10/27/26 | ||
| Brian Meredith | UBS | $275 | hold | 4.34%Upside | Assigned | 10/20/26 | ||
| Meyer Shields | KBW | $232 | sell | -11.98%Downside | Reiterated | 10/16/26 | ||
| Elyse Greenspan | Wells Fargo | $236 | hold | -10.46%Downside | Assigned | 10/16/26 | ||
| Bob Huang | Morgan Stanley | $240 | hold | -8.94%Downside | Assigned | 10/16/26 | ||
| Alex Scott | Barclays | $226→$221 | sell | -16.15%Downside | Reiterated | 10/07/26 | ||
| Vikram Gandhi | HSBC | $282→$266 | buy | 0.92%Upside | Upgraded | 10/07/26 | ||
| Yaron Kinar | Mizuho Securities | $300→$295 | buy | 11.92%Upside | Reiterated | 10/07/26 | ||
| Matthew Heimermann | Citi | $240→$215 | sell | -18.43%Downside | Reiterated | 10/05/26 | ||
| Robert Cox CFA | Goldman Sachs | $280→$250 | hold | -5.15%Downside | Reiterated | 10/05/26 | ||
| Paul Newsome | Piper Sandler | $300 | buy | 13.82%Upside | Reiterated | 09/28/26 | ||
| David Motemaden | Evercore ISI | $262 | hold | -0.60%Downside | Reiterated | 09/21/26 | ||
| Kevin Heal | Argus Research | $238 | hold | -9.70%Downside | Downgraded | 08/27/26 | ||
| Michael Zaremski | BMO Capital | $250→$284 | buy | 7.75%Upside | Assigned | 08/13/26 | ||
| Pablo Singzon | J.P. Morgan | $282→$292 | buy | 10.79%Upside | Reiterated | 08/11/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Joshua Shanker | 10/27/26 | ― | buy | ― | Reiterated | Bank of America Securities | ||
| Brian Meredith | 10/20/26 | $275 | hold | 4.34%Upside | Assigned | UBS | ||
| Meyer Shields | 10/16/26 | $232 | sell | -11.98%Downside | Reiterated | KBW | ||
| Elyse Greenspan | 10/16/26 | $236 | hold | -10.46%Downside | Assigned | Wells Fargo | ||
| Bob Huang | 10/16/26 | $240 | hold | -8.94%Downside | Assigned | Morgan Stanley | ||
| Alex Scott | 10/07/26 | $226→$221 | sell | -16.15%Downside | Reiterated | Barclays | ||
| Vikram Gandhi | 10/07/26 | $282→$266 | buy | 0.92%Upside | Upgraded | HSBC | ||
| Yaron Kinar | 10/07/26 | $300→$295 | buy | 11.92%Upside | Reiterated | Mizuho Securities | ||
| Matthew Heimermann | 10/05/26 | $240→$215 | sell | -18.43%Downside | Reiterated | Citi | ||
| Robert Cox CFA | 10/05/26 | $280→$250 | hold | -5.15%Downside | Reiterated | Goldman Sachs | ||
| Paul Newsome | 09/28/26 | $300 | buy | 13.82%Upside | Reiterated | Piper Sandler | ||
| David Motemaden | 09/21/26 | $262 | hold | -0.60%Downside | Reiterated | Evercore ISI | ||
| Kevin Heal | 08/27/26 | $238 | hold | -9.70%Downside | Downgraded | Argus Research | ||
| Michael Zaremski | 08/13/26 | $250→$284 | buy | 7.75%Upside | Assigned | BMO Capital | ||
| Pablo Singzon | 08/11/26 | $282→$292 | buy | 10.79%Upside | Reiterated | J.P. Morgan |
Stocks with the Highest Top Analyst Consensus in the Financial Sector
Best Analysts Covering Allstate
3 Months
Success Rate17/21 ratings generated profit
81%
Average Return
+6.00%
Copying Yaron Kinar's trades and holding each position for 3 Months would result in 80.95% of your transactions generating a profit, with an average return of +6.00% per trade.
1 Year
Success Rate20/21 ratings generated profit
95%
Average Return
+16.52%
Copying Yaron Kinar's trades and holding each position for 1 Year would result in 95.24% of your transactions generating a profit, with an average return of +16.52% per trade.
2 Years
Success Rate23/24 ratings generated profit
96%
Average Return
+28.18%
Copying Harry Fong's trades and holding each position for 2 Years would result in 95.83% of your transactions generating a profit, with an average return of +28.18% per trade.
0HCZ Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 13 | 14 | 19 | 22 | 20 |
| Hold | 11 | 18 | 22 | 20 | 16 |
| Sell | 5 | 5 | 9 | 8 | 10 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 29 | 37 | 50 | 50 | 46 |
In the current month, 0HCZ has received 20 Buy Ratings, 16 Hold Ratings, and 10 Sell Ratings. 0HCZ average Analyst price target in the past 3 months is 264.44.
0HCZ Financial Forecast
High$8.67
Consensus$6.89
Low$5.35
0HCZ Earnings Forecast
Next quarter’s earnings estimate for 0HCZ is $6.89 with a range of $5.35 to $8.67. The previous quarter’s EPS was $8.99. Its overall industry beat the EPS estimate 81.82% of the time in the past 12 months.
High$16.2B
Consensus$15.9B
Low$14.8B
0HCZ Sales Forecast
Next quarter’s sales forecast for 0HCZ is $15.87B with a range of $14.84B to $16.21B. The previous quarter’s sales results were $18.60B. Its overall industry beat sales estimates 93.33% of the time in the past 12 months.
0HCZ Stock Forecast FAQ
What is GB:0HCZ’s average 12-month price target, according to analysts?
Based on analyst ratings, Allstate’s 12-month average price target is $264.44.
What is GB:0HCZ’s upside potential, based on the analysts’ average price target?
Allstate has 0.33% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Allstate a Buy, Sell or Hold?
Allstate has a consensus rating of Moderate Buy, which is based on 9 buy ratings, 8 hold ratings and 3 sell ratings.
What is Allstate’s share price target?
The average share price target for Allstate is $264.44. This is based on 20 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is $315.00, and the lowest forecast is $215.00. The average share price target represents a 0.33% increase from the current price of $263.57.
What do analysts say about Allstate?
Allstate’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 20 Wall Street analysts.
How can I buy shares of Allstate?
To buy shares of GB:0HCZ, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
